Barclays’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $80.9M | Sell |
|
|||||
|
2023
Q2 | $101M | Sell |
|
|||||
|
2023
Q1 | $169M | Buy |
|
|||||
|
2022
Q4 | $86.2M | Sell |
|
|||||
|
2022
Q3 | $238M | Buy |
|
|||||
|
2022
Q2 | $23M | Sell |
|
|||||
|
2022
Q1 | $60.6M | Buy |
|
|||||
|
2021
Q4 | $16.9M | Sell |
|
|||||
|
2021
Q3 | $21.1M | Sell |
|
|||||
|
2021
Q2 | $19.6M | Buy |
|
|||||
|
2021
Q1 | $15.4M | Buy |
|
|||||
|
2020
Q4 | $7M | Buy |
|
|||||
|
2020
Q3 | $359K | Sell |
|
|||||
|
2020
Q2 | $449K | Sell |
|
|||||
|
2020
Q1 | $282K | Sell |
|
|||||
|
2019
Q4 | $987K | Sell |
|
|||||
|
2019
Q3 | $4.65M | Sell |
|
|||||
|
2019
Q2 | $9.79M | Buy |
|
|||||
|
2019
Q1 | $3.61M | Buy |
|
|||||
|
2018
Q4 | $640K | Sell |
|
|||||
|
2018
Q3 | $3.03M | Sell |
|
|||||
|
2018
Q2 | $2.98M | Sell |
|
|||||
|
2018
Q1 | $3.07M | Sell |
|
|||||
|
2017
Q4 | $5.32M | Sell |
|
|||||
|
2017
Q3 | $20M | Buy |
|
|||||
|
2017
Q2 | $1.92M | Sell |
|
|||||
|
2017
Q1 | $19.2M | Buy |
|
|||||
|
2016
Q4 | $2.53M | Sell |
|
|||||
|
2016
Q3 | $2.86M | Sell |
|
|||||
|
2016
Q2 | $4.85M | Buy |
|
|||||
|
2016
Q1 | $2.28M | Sell |
|
|||||
|
2015
Q4 | $6.04M | Buy |
|
|||||
|
2015
Q3 | $3.57M | Buy |
|
|||||
|
2015
Q2 | $4.12M | Buy |
|
|||||
|
2015
Q1 | $478K | Buy |
|
|||||
|
2014
Q4 | $77K | Sell |
|
|||||
|
2014
Q3 | $383K | Buy |
|
|||||
|
2014
Q2 | $196K | Sell |
|
|||||
|
2014
Q1 | $217K | Buy |
|
|||||
|
2013
Q4 | $20K | Buy |
|
|||||
|
2013
Q3 | $4K | Sell |
|
|||||
|
2013
Q2 | $4K | Buy |
|